Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 10/20 | 1.00 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 1.00 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.82 |
| ▸ | HSP90B1 | P14625 | 3/20 | 0.82 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.82 |
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.77 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | THRB | P10828 | 1/20 | 0.75 |
| ▸ | BLM | P54132 | 1/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.75 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.75 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.71 |
| ▸ | HRH1 | P35367 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 5'-Carboxy Adenosine SCHEMBL29376409 | 1.00 | AHCY (1.00) | AHCYTMEM97HIF1ASIGMAR1ADORA2B | |
| 5'-Carboxy Adenosine SCHEMBL8981282 | 1.00 | AHCY (1.00) | AHCYTMEM97HIF1ASIGMAR1ADORA2B | |
| 5'-Carboxy Adenosine SCHEMBL3815016 | 1.00 | AHCY (1.00) | AHCYTMEM97HIF1ASIGMAR1ADORA2B | |
| 5'-Carboxy Adenosine SCHEMBL2117257 | 1.00 | AHCY (1.00) | AHCYTMEM97HIF1ASIGMAR1ADORA2B | |
| 5'-Carboxy Adenosine SCHEMBL27863662 | 0.95 | AHCY (0.91) | AHCYTMEM97HIF1ASIGMAR1ADORA2B | |
| SCHEMBL10883314 | 0.90 | AHCY (0.82) | AHCYTMEM97HIF1ASIGMAR1ADORA2B | |
| SCHEMBL13889874 | 0.90 | AHCY (1.00) | AHCYTMEM97HIF1ASIGMAR1ADORA2B | |
| SCHEMBL22354804 | 0.90 | AHCY (1.00) | AHCYTMEM97HIF1ASIGMAR1ADORA2B | |
| SCHEMBL19189542 | 0.89 | AHCY (0.80) | AHCYTMEM97HIF1ASIGMAR1ADORA2B | |
| SCHEMBL19190163 | 0.89 | AHCY (0.80) | AHCYTMEM97HIF1ASIGMAR1ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4403042-A2 | FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME | Mars, Incorporated (US) | 2024-07-24 | — | — | EP | disclosed |
| EP-3229612-B1 | USE OF FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS INC (US) | 2024-06-26 | — | — | EP | disclosed |
| US-11185100-B2 | Methods for modulating taste receptors | MARS, INCORPORATED (US) | 2021-11-30 | — | — | US | disclosed |
| EP-3229610-B1 | FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS INC (US) | 2021-06-09 | — | — | EP | disclosed |
| US-20190021380-A1 | FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS, INCORPORATED (US) | 2019-01-24 | — | — | US | disclosed |
| US-20180355369-A1 | Method for Increasing Plant Stress Tolerance and Seed Dormancy | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2018-12-13 | — | — | US | disclosed |
| US-20180255813-A1 | METHODS FOR MODULATING TASTE RECEPTORS | MARS, INCORPORATED (US) | 2018-09-13 | — | — | US | disclosed |
| US-20180168208-A1 | FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS, INCORPORATED (US) | 2018-06-21 | — | — | US | disclosed |
| EP-2482072-B1 | A PHOTOLUMINESCENT PROBE | UNIV TARTU (EE) | 2016-07-06 | — | — | EP | disclosed |
| US-20140057284-A1 | PHOTOLUMINESCENT MOLECULAR COMPLEX AND METHOD FOR DETERMINING OF THE CONCENTRATION OF SAID MOLECULAR COMPLEX | UNIVERSITY OF TARTU (EE) | 2014-02-27 | — | — | US | disclosed |
| EP-2482072-A1 | A photoluminescent probe | University of Tartu (EE) | 2012-08-01 | — | — | EP | disclosed |
| US-8158376-B2 | Bisubstrate fluorescent probe binding to protein kinases | UNIVERSITY OF TARTU (EE) | 2012-04-17 | — | — | US | disclosed |
| US-20100233743-A1 | BISUBSTRATE FLUORESCENT PROBE BINDING TO PROTEIN KINASES | UNIVERSITY OF TARTU (EE) | 2010-09-16 | — | — | US | disclosed |
| EP-2057279-A2 | BISUBSTRATE FLUORESCENT PROBE BINDING TO PROTEIN KINASES | University of Tartu (EE) | 2009-05-13 | — | — | EP | disclosed |
| WO-2008019696-A2 | BISUBSTRATE FLUORESCENT PROBE BINDING TO PROTEIN KINASES | UNIVERSITY OF TARTU (EE) | 2008-02-21 | — | — | WO | disclosed |
| EP-1482977-A1 | COMBINATION THERAPIES FOR TREATING METHYLTHIOADENOSINE PHOSPHORYLASE DEFICIENT CELLS | PFIZER INC. (US) | 2004-12-08 | — | — | EP | disclosed |
| US-20040043959-A1 | Combination therapies for treating methylthioadenosine phosphorylase deficient cells | AGOURON PHARMACEUTICALS INC. | 2004-03-04 | — | — | US | disclosed |
| WO-2003074083-A1 | COMBINATION THERAPIES FOR TREATING METHYLTHIOADENOSINE PHOSPHORYLASE DEFICIENT CELLS | PFIZER INC. (US) | 2003-09-12 | — | — | WO | disclosed |
| US-6534651-B2 | Substituted isoindolinone derivatives | INOTEK PHARMACEUTICALS CORP. | 2003-03-18 | — | — | US | disclosed |
| US-6534651-B2 | Substituted isoindolinone derivatives | INOTEK PHARMACEUTICALS CORP. | 2003-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233743-A1 | BISUBSTRATE FLUORESCENT PROBE BINDING TO PROTEIN KINASES | ADK, PRKCH, DMPK | AHCY 1747/4885TMEM97 2390/4885HIF1A 2475/4885 |
| US-20040043959-A1 | Combination therapies for treating methylthioadenosine phosphorylase deficient cells | APRT, MTAP, TYMP | AHCY 62/4885TMEM97 4737/4885HIF1A 3905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.